این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
چهارشنبه 29 بهمن 1404
International Journal of Hematology-Oncology and Stem Cell Research
، جلد ۱۹، شماره ۱، صفحات ۳۷-۴۲
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Minimal Residual Disease in Acute Lymphoblastic Leukaemia and Its Relationship with Other Prognostic Factors
چکیده انگلیسی مقاله
Background: Minimal Residual Disease (MRD) assessment is crucial for directing treatment decisions in Acute Lymphoblastic Leukemia (ALL). In low- and middle-income countries, limited resources can present challenges to implementing MRD-guided therapy intensification for ALL. The study attempted to assess the relationship between MRD and other prognostic factors in ALL, focusing on treatment outcomes and disease progression. Materials and Methods: A retrospective observational study was conducted at Ramaiah Medical College and Hospital in Bengaluru, examining patient data from January 2021 to December 2021. MRD status was determined post-induction using flow cytometry. Patients were classified into various groups based on factors such as type of ALL (B-cell or T-cell), NCI risk status (standard or high), cytogenetic risk (favorable, poor, or intermediate), CNS status, prednisone response, and MRD levels at the end of induction. Results: Out of 72 patients, 25% were MRD-positive, with a male: female ratio of 2.13:1. B-ALL was diagnosed in 49 patients and T-ALL in 23, with 75% categorized as high-risk by NCI criteria. Cytogenetic analysis revealed a diverse profile (23.61% PR, 48.61% IR, 27.78% FR), and 58.33% exhibited a good prednisone response (GPR). At the end of the induction phase, 25% tested positive for MRD, with B-ALL showing a lower MRD rate at 15.2%. Age and NCI risk status significantly influenced MRD outcomes, with 75% of participants classified as high-risk. Conclusion: This study demonstrates a significant association between MRD positivity and factors such as age, NCI risk status, and B-ALL diagnosis, underscoring the complex interaction of these variables in predicting treatment outcomes for ALL patients.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
| Chinmayee Agrawal
Department of Medical Oncology, Ramaiah Medical College, Bengaluru, India
| Sai Boppana
Department of Medical Oncology, NRI Medical College and Hospital, Mangalagiri, Andhra Pradesh, India
| Santhosh Devdas
Department of Medical Oncology, Ramaiah Medical College, Bengaluru, India
| Vinayak Maka
Department of Medical Oncology, Ramaiah Medical College, Bengaluru, India
| Nalini Kilara
Department of Medical Oncology, Ramaiah Medical College, Bengaluru, India
| Swaratika Majumdar
Department of Medical Oncology, Ramaiah Medical College, Bengaluru, India
| Rasmi Palassery
Department of Medical Oncology, Ramaiah Medical College, Bengaluru, India
نشانی اینترنتی
https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/2095
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات